Cassidy & Associates Attorneys at Law 215 Apolena Avenue Newport Beach, California 92662 ---------- Email: CassidyLaw@aol.com Telephone: 202/387-5400 Fax: 949/673-4525 September 20, 2011 Jeffrey Riedler United States Securities and Exchange Commission 100 F Street, N.E. Washington, D.C. 20549 Re: BioPharma Manufacturing Solutions Inc. formerly Beachwood Acquisition Corporation Form 8-K/A File No. 000-54423 Mr. Riedler: Attached for filing with the Securities and Exchange Commission in response to the Commission's letter of September 12, 2011,is the BioPharma Manufacturing Solutions Inc. (formerly Beachwood Acquisition Corporation) Form 8-K/A. The following responses address the comments of the reviewing staff of the Commission as set forth in its comment letter. Item 5.01 1. The disclosure has been added as paragraph #3 in Item 5.01. 2. There was no written Securities Purchase Agreement and the change of control was effected through action and consents by the Board of Directors and shareholders. Item 5.02 3. The disclosure has been revised to include Mr. Riccio's business experience and principal occupation for the past five years. Sincerely, Lee W. Cassidy